Esperion Therapeutics, Inc.
2019 Q4 - 2025 Q4 (23 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/17/2026 | 3,463 | 0.0% | 935,919 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 2,529 | 0.0% | 954,449 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 823 | 0.0% | 836,461 | 6/30/2025 |
| 2025 Q1 | 5/14/2025 | 1,098 | 0.0% | 762,633 | 3/31/2025 |
| 2024 Q4 | 2/14/2025 | 1,602 | 0.0% | 728,232 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 1,247 | 0.0% | 756,027 | 9/30/2024 |
| 2024 Q2 | 8/15/2024 | 1,152 | 0.0% | 518,958 | 6/30/2024 |
| 2024 Q1 | 5/7/2024 | 5,483 | 0.0% | 2,045,769 | 3/31/2024 |
| 2023 Q4 | 2/14/2024 | 4,157 | 0.0% | 1,390,274 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 586 | 0.0% | 597,840 | 9/30/2023 |
| 2023 Q2 | 8/11/2023 | 894 | 0.0% | 643,072 | 6/30/2023 |
| 2023 Q1 | 5/16/2023 | 490 | 0.0% | 308,011 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 980 | 0.0% | 157,235 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 167 | 0.0% | 24,851 | 9/30/2022 |
| 2022 Q1 | 5/16/2022 | 451 | 0.0% | 97,136 | 3/31/2022 |
| 2021 Q3 | 11/15/2021 | 501 | 0.0% | 41,597 | 9/30/2021 |
| 2021 Q2 | 8/11/2021 | 4,227 | 0.0% | 199,846 | 6/30/2021 |
| 2021 Q1 | 5/17/2021 | 4,974 | 0.0% | 177,316 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 1,255 | 0.0% | 48,276 | 12/31/2020 |
| 2020 Q3 | 11/16/2020 | 672 | 0.0% | 18,085 | 9/30/2020 |
| 2020 Q2 | 8/14/2020 | 6,990 | 0.0% | 136,239 | 6/30/2020 |
| 2020 Q1 | 5/15/2020 | 5,957 | 0.0% | 188,929 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 7,444 | 0.0% | 124,838 | 12/31/2019 |